Brief: Lisata Therapeutics Q2 EPS USD -0.5
14/08/2023 23:19
Aug 14 (Reuters) - Lisata Therapeutics Q2 net income USD -4.027 million. * Q2 EPS USD -0.5 * Q2 operating expenses USD 6.875 million * Q2 operating income USD -6.875 million
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco